跳至主要内容
临床试验/CTRI/2022/05/042344
CTRI/2022/05/042344已完成2 期

evel IB dissection with Intact Submandibular gland versus En bloc Level IB dissection for Oral cavity cancers : A Parallel design, Single centre, Open label, Non-inferiority Randomised Controlled Trial

AIIMS Rishikesh0 个研究点目标入组 46 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age > 18 years
  • Biopsy proven Oral cavity Squamous cell cancer
  • TNM staging : Any T, N0(Clinico-radiological), M0 according to AJCC, 8th ed.
  • Planned for upfront surgery
  • Willing to participate in the study

排除标准

  • Age < 18 years
  • Presence of contiguous tumour extension into Level IB or Involvement of Submandibular gland by the tumour
  • Paramandibular spread of the disease
  • Node positivity (Clinico-radiological)
  • Distant metastasis on presentation
  • Presence of major co-morbidities making the patient unfit for surgery
  • Recurrent Oral cavity cancer or Second primar Oral cavity tumour
  • Any history of prior radiation therapy to Head and Neck region
  • Any history of Neoadjuvant therapy for Oral cavity malignancy
  • Any past history of extensive surgery in Oral cavity or Neck, that might have resulted in disruption of lymphatics

研究者

相似试验

evel IB dissection with Intact Submandibular gland... | 临床试验